Cumberland Pharmaceuticals Inc.;Vanderbilt University
发明人:
Leo PAVLIV,James WEST,Ines Macias-Perez,Erica Carrier
申请号：
US16578294
公开号：
US20200030298A1
申请日:
2019.09.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
